Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis
Authors
Keywords
-
Journal
Microbiology Spectrum
Volume 10, Issue 1, Pages -
Publisher
American Society for Microbiology
Online
2022-02-16
DOI
10.1128/spectrum.02477-21
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts
- (2021) Jeremiah Chakaya et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- PASP: Property analysis and simulation package for materials
- (2021) Feng Lou et al. JOURNAL OF CHEMICAL PHYSICS
- Early outcome and safety of bedaquiline-containing regimens for treatment of MDR- and XDR-TB in China: a multicentre study
- (2020) M. Gao et al. CLINICAL MICROBIOLOGY AND INFECTION
- Identifying regimens containing a new drug candidate TBI-166 against Mycobacterium tuberculosis in vitro and in vivo
- (2019) Ye Zhang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel
- (2019) Hamish S. Sutherland et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A structural insight of bedaquiline for the cardiotoxicity and hepatotoxicity
- (2019) Harun Patel et al. TUBERCULOSIS
- A safety evaluation of bedaquiline for the treatment of multi-drug resistant tuberculosis
- (2019) Karen Cohen et al. Expert Opinion On Drug Safety
- In vitro activity of PBTZ169 against multiple Mycobacterium species
- (2018) Jin Shi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
- (2018) Nafees Ahmad et al. LANCET
- Relevance of Half-Life in Drug Design
- (2017) Dennis A. Smith et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis
- (2017) Ji-Chan Jang et al. JOURNAL OF MICROBIOLOGY
- Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice
- (2016) Scott M. Irwin et al. ACS Infectious Diseases
- Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
- (2015) Alexander S. Pym et al. EUROPEAN RESPIRATORY JOURNAL
- Bedaquiline susceptibility testing ofMycobacterium tuberculosisin an automated liquid culture system
- (2015) Gabriela Torrea et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Human cardiac troponin complex. Structure and functions
- (2014) I. A. Katrukha BIOCHEMISTRY-MOSCOW
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
- (2014) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
- (2014) Anil Koul et al. Nature Communications
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
- (2012) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation
- (2011) Yu Lu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sterilizing Activity of Novel TMC207- and PA-824-Containing Regimens in a Murine Model of Tuberculosis
- (2011) Rokeya Tasneen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of TMC207 and ItsN-Desmethyl Metabolite in a Murine Model of Tuberculosis
- (2011) Marie-Claude Rouan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phospholipidosis as a Function of Basicity, Lipophilicity, and Volume of Distribution of Compounds
- (2010) Umesh M. Hanumegowda et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells
- (2010) Jasvir Dhillon et al. TUBERCULOSIS
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now